Note: Compounded drugs are not approved by the U.S. Food and Drug Administration (FDA) and may carry greater risks than FDA-approved treatments. Despite recent price reductions, GLP-1 weight loss ...

GLP-1s currently make up a small portion of Medicaid prescriptions and spending before rebates are applied, but their share is growing. In 2023, GLP-1s accounted for 0.5% of prescriptions — compared ...

The increasing use of GLP-1s for weight loss, instead of solely type 2 diabetes management, is putting employers in a tricky position, according to research released Oct. 22 by The Peterson Center on ...

Initially developed to treat diabetes by regulating blood sugar levels, GLP-1 medication has become increasingly popular for losing weight. Recent surveys found that 60 percent of people taking ...

Nearly half of Gen Z says company coverage of weight-loss drugs would determine which jobs they take. And they’re not the ...

A recent survey found that up to 4 in 10 employers intend to cover GLP-1 drugs in 2024, up from the 25% of employers that currently cover the medications. Employer sentiment toward GLP-1 drugs showed ...

There's good news for those hoping to use these drugs for weight loss.

What Are GLP-1 Drugs? Injectable GLP-1 (glucagon-like peptide-1) receptor agonists were first introduced for managing Type 2 diabetes, a condition that affects over a quarter of Medicare beneficiaries ...

Despite the boom in popularity of expensive GLP-1 drugs to treat weight loss, fewer than one in five large employers are covering such prescriptions, a new KFF analysis shows. In this photo is Ozempic ...

This story was originally published on HR Dive. To receive daily news and insights, subscribe to our free daily HR Dive newsletter. Companies on the fence about offering an employee benefits plan that ...

The healthcare industry is embroiled in a fierce debate over if — and how — GLP-1s should be covered for weight loss. Unclear long-term efficacy, combined with an exorbitant price tag, is restraining ...

Companies on the fence about offering an employee benefits plan that covers GLP-1s may find the following data helpful: A report from risk consultation firm Aon, released Jan. 13, suggests workers’ ...